Navigation Links
Former President of Sports Cardiology Consultants, LLC Christine Lawless, MD, MBA, ABCL, FACC, FACSM, Named Medical Director of CME Enterprise
Date:3/10/2009

CARMEL, Ind., March 10 /PRNewswire/ -- Christine Lawless, MD, has accepted the position as Medical Director of CME Enterprise, an ACCME-accredited provider of continuing medical education (CME), beginning March 2, 2009. Recognized as one of the world's leading authorities in sports medicine cardiology, Dr. Lawless recently completed her clinical tenure at The Ohio State University Medical Center, where she was Associate Professor of Internal Medicine and Co-Director of Ross Heart Hospital Lipid Clinic.

"Placing Dr. Lawless as Medical Director greatly increases opportunities to engage in cardiovascular and sports medicine, ensuring that the CME Enterprise team will continue its growth as a consummate professional education resource for quality CME," said CME Enterprise owner Deborah Wood.

"I look forward to working with my new colleagues at CME Enterprise as we continue to develop the most relevant curriculum for healthcare professionals," said Dr. Lawless. "The areas of greatest interest and expertise that I bring to CME Enterprise include preventive cardiology, lipids, hypertension, cardiomyopathy, heart disease in athletes, sports cardiology, sudden cardiac arrest and sports medicine."

Dr. Lawless is board certified in internal medicine, cardiovascular disease clinical lipidology¸ and sports medicine. She also is Chair of the US Figure Skating Sports Sciences and Sports Medicine Committee and also Head Team Physician for US Figure Skating. Dr. Lawless serves on the Advisory Board for the National Sudden Cardiac Arrest Association. She holds many other appointments in academic medicine and hospital-based clinical care. "With her expertise and extensive experience in academic and clinical medicine, Dr. Lawless will enable CME Enterprise to establish educational excellence not only in cardiovascular science, but also internal sports medicine for athletes," said CME Enterprise President Bru
'/>"/>

SOURCE CME Enterprise
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Former Patent Office Solicitor and Judge Joins Rothwell Figg
8. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
9. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
10. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
11. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...TUSTIN, Calif., Dec. 2 P...day reported completion of patient enrollment in a...174; in patients with relapsed glioblastoma multif...otara is a targeted monoclonal antibody linked to ...treatment for GBM. Cotara specifically targets ce...
(Date:12/2/2009)..., CAMBRIDGE, Mass., Dec. 2 TechCo...s in technology development and product integratio...ced the December 11th deadline for technology abst... 14th year, TechConnect World, in association with... and the Clean Technology and Sustainable Industri...
(Date:12/2/2009)... NANJING, China, Dec. 2 /PRNewswire-Asia/ -- Si...any") (NYSE: SCR ), a leading pharmaceutical com...g, and marketing of branded,generic and proprietar...05 of,its drugs have been included in China,s Nati...ssued by China,s Ministry of Human Resources and S...
(Date:12/2/2009)...BOKEN, N.J., Dec. 2 According to t...percent of Americans diagnosed with diabetes alrea...tic retinopathy, damage to the retina caused by le...n people with diabetes and is one of the most fear...ent of all patients who,ve had diabetes for 10 yea...
Breaking Biology Technology:Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 2Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 3Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 4Peregrine Completes Patient Enrollment in Cotara(R) Dose Confirmation and Dosimetry Brain Cancer Trial 5Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...werful engine that propels the bacterium Bacillus...corkscrew-like flagellum by a protein clutch, Indi...scientists have learned. Their report appears in t...wn what drives the flagellum to spin, but what cau...or permanently -- was unknown. , "We think it,s ...
...e Northeast Ohio,venture development organization ...age businesses and ideas, has announced an investm...iop Technologies, LLC. The JumpStart,investment is...ncluded $1,million from RMS Management of Clevelan...nh/20060209/CLJUMPSTARTLOGO ), Tursiop is develo...
...eering Committee will Identify, Antibody Targets i...search to be Produced by Sigma-...q:,SIAL) today announced it has entered into a fiv... for the production of monoclonal antibodies.,Scie...sco will lead the,research into antibodies for a v...
Other Biology Technology:Microscopic 'clutch' puts flagellum in neutral 2Microscopic 'clutch' puts flagellum in neutral 3JumpStart Invests in Tursiop Technologies 2JumpStart Invests in Tursiop Technologies 3Sigma-Aldrich Announces Collaboration to Develop Monoclonal Antibodies 2Sigma-Aldrich Announces Collaboration to Develop Monoclonal Antibodies 3
(Date:12/2/2009)... , REDWOOD SHORES, Calif. and PALM HA...nication Intelligence Corporation ("CIC") (OTC Bul...ic signature solutions for business process automa... leader** in biometric signature verification and ...rnational Electronic Document Management (EDM) sof...
(Date:12/2/2009)...ally Hall, a PhD student at the University of Sout... at the National Oceanography Centre, Southampton ...king crab, all from the deep sea. , Hall discove... of the National Museum of Natural History in Wash...he said: "King crabs include some of the largest c...
(Date:12/1/2009)... , SUNNYVALE, Calif., Dec. 1 /PRNewswire/ ...he CUBE, Release 3.0 - a turnkey, portable, plug a...advertising, exhibits, entertainment and touring p...f dozens of patents in camera-enabled gesture reco...tation and entertainment systems. ,, Guaranteed...
Breaking Biology News(10 mins):CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4King crab family bigger than ever 2GestureTek Unveils The CUBE V3 Portable, Plug and Play Interactive Projection Display System for Advertising and Exhibits 2Pitt researchers find promising candidate protein for cancer prevention vaccines 9472 1Pitt researchers find promising candidate protein for cancer prevention vaccines 9472 2Aetna 28 Percent Profit Drop Signals Storm Clouds for Healthcare 53650 1Aetna 28 Percent Profit Drop Signals Storm Clouds for Healthcare 53650 2Back to School Parents Earn an A+ in Safety 3A Backpacks Cheerleading Football 53646 1Back to School Parents Earn an A+ in Safety 3A Backpacks Cheerleading Football 53646 2Back to School Parents Earn an A+ in Safety 3A Backpacks Cheerleading Football 53646 3Back to School Parents Earn an A+ in Safety 3A Backpacks Cheerleading Football 53646 4
...age (cirrhosis) and failure may benefit from resea...on which may lead to new,life-saving treatments. T...a patient,s only hope of survival is to receive a ...e University,s Centre for Inflammation,Research, i...y of,Southampton and Cincinnati, USA have, for the...
...d of care for patients with relapsed lymphoma, but...e and HIV. A new study showing,that this treatment...ssociated lymphoma will be published in the Januar...f the American Society of,Hematology.,Because of t...ive,patients are more likely to develop lymphoma t...
...tem of insects may have solved a mystery that has ...outinely stop breathing for minutes at a time. , ...rvine and Humboldt University propose that insects...pes of fruit flies, beetles and bugs close off the...cess oxygen, thus preventing damage to their tissu...
Other Biology News:Research Gives Hope For Liver Damage 2Potential Cure for Lymphoma in HIV patients 2Potential Cure for Lymphoma in HIV patients 3Why do insects stop 'breathing'? To avoid damage from too much oxygen, say researchers 2Why do insects stop 'breathing'? To avoid damage from too much oxygen, say researchers 3
GIBCO Sf-900 II SFM (1X) liquid from Invitrogen
GIBCO Graces Insect Cell Culture Medium; powder from Invitrogen
BD LSR II System from BD Biosciences - Immunocytometry Systems
Bovine Calf Blood Non-Sterile Alsevers from Pel-Freez Biologicals
Biology Products: